The activation of NLRP3 inflammasome pathway in COPD is limited in local airways

J. Fu (Chengdu, China), B. Mao (Chengdu, China), S. Wang (Chengdu, China), W. Xiao (Chengdu, China), G. Li (Chengdu, China), L. Wu (Chengdu, China)

Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Session: Disease exacerbations from a molecular point of view
Session type: Poster Discussion
Number: 4981
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Fu (Chengdu, China), B. Mao (Chengdu, China), S. Wang (Chengdu, China), W. Xiao (Chengdu, China), G. Li (Chengdu, China), L. Wu (Chengdu, China). The activation of NLRP3 inflammasome pathway in COPD is limited in local airways. 4981

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Activation of the inflammasome pathway during exacerbations of COPD
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011


The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation
Source: Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019
Year: 2020



Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis
Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020
Year: 2020



Caspase-1 pathway in COPD
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010


Elevated expression of the NLRP3 inflammasome in neutrophilic asthma
Source: Eur Respir J 2014; 43: 1067-1076
Year: 2014



Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension
Source: International Congress 2017 – Experimental PH
Year: 2017


NLRP3 inflammasome conjugates with mitochondria in LPS-induced acute lung injury
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019

Cigarette smoke extract inhibits the NLRP3 inflammasome in human macrophages and impairs cell metabolism via NLRP3-independent activation of Caspase-1
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019

The NLRP3 inflammasome is not activated in airway smooth muscle upon TLR2 ligation
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Activation of IL-32 pathway in COPD
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008

Role of NLRP3 inflammasome and ATP in S100A12-induced MUC5AC production in airway epithelial cells
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018




Rhinovirus triggers increased inflammasome activation in human bronchial epithelium in asthma.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Activation of NLRP3 inflammasome is regulated by mitochondrial ROS via PI3K-HIF-VEGF pathway in acute lung injury
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015


Silica-induced inflammasome activation in lung epithelial cells
Source: Annual Congress 2012 - Abestosis, silicosis and hypersensitivity pneumonitis
Year: 2012

The inflammasome pathway in stable COPD and acute exacerbations
Source: ERJ Open Res 2016: 00002-2016
Year: 2016